Skip to Content

Petlife Pharmaceuticals Inc PTLF Stock Quote

| Rating as of


Morningstar‘s Stock Analysis PTLF

Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics PTLF

Company Profile PTLF

Business Description

Petlife Pharmaceuticals Inc specializes in the research, development, sales, and support of advanced drugs and nutraceuticals for pet cancer and autoimmune related diseases such as arthritis. It develops potentiated veterinary cancer medications and nutraceuticals, under its tradename Vitalzul based on Escozine formula. The Vitalzul is a polarized, bioactive peptide extracted from the Blue Caribbean Scorpion (Rhopularus Princeps), which contains amino acids, proteins, and minerals.

38 West Main Street, 6th Floor
Hancock, MD, 21750
T +1 844 473-8543
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Feb 28, 2018
Fiscal Year End Aug 31, 2018
Employees 1